{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:55:58Z","timestamp":1790070958040,"version":"4.0.1"},"reference-count":29,"publisher":"National Academy of Sciences","issue":"10","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":181,"URL":"http:\/\/www.pnas.org\/site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401880"],"award-info":[{"award-number":["81401880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373621"],"award-info":[{"award-number":["81373621"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1U54 CA199090-01"],"award-info":[{"award-number":["1U54 CA199090-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2017,3,7]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Identification of cancer cells in the pleural effusions of lung cancer patients is an important clinical diagnosis to verify the malignant pleural involvement. Elevated glucose uptake is a hallmark of cancer cells and has been used in positron-emission tomography to detect malignant tumors in vivo. We hypothesize that cells with enhanced glucose uptake and without expression of leukocyte markers in pleural effusion or peripheral blood samples are highly likely to be malignant cells that can be confirmed via single-cell sequencing. To this end, a high-throughput metabolic-based assay is developed for rapid detection of rare metabolically active tumor cells in pleural effusion, enabling sensitive diagnosis of malignant pleural effusion in the clinic that is associated with metastatic malignancies.<\/jats:p>","DOI":"10.1073\/pnas.1612229114","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T20:40:29Z","timestamp":1487709629000},"page":"2544-2549","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":72,"title":["High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients"],"prefix":"10.1073","volume":"114","author":[{"given":"Yin","family":"Tang","sequence":"first","affiliation":[{"name":"Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwoo","family":"Kim","sequence":"additional","affiliation":[{"name":"NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125;"},{"name":"Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Deng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, 200071, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Heath","sequence":"additional","affiliation":[{"name":"NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125;"},{"name":"Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125;"},{"name":"Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125;"},{"name":"Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Shi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMcp010731","article-title":"Clinical practice. Pleural effusion","volume":"346","author":"Light RW","year":"2002","unstructured":"RW Light, Clinical practice. Pleural effusion. N Engl J Med 346, 1971\u20131977 (2002).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1843.2007.01154.x","article-title":"Diagnosis and management of malignant pleural effusions","volume":"13","author":"Heffner JE","year":"2008","unstructured":"JE Heffner, Diagnosis and management of malignant pleural effusions. Respirology 13, 5\u201320 (2008).","journal-title":"Respirology"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccm.2012.11.002","article-title":"Pleural fluid biomarkers: Beyond the Light criteria","volume":"34","author":"Porcel JM","year":"2013","unstructured":"JM Porcel, Pleural fluid biomarkers: Beyond the Light criteria. Clin Chest Med 34, 27\u201337 (2013).","journal-title":"Clin Chest Med"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrclinonc.2013.253","article-title":"Molecular analysis of circulating tumour cells-biology and biomarkers","volume":"11","author":"Krebs MG","year":"2014","unstructured":"MG Krebs, , Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 11, 129\u2013144 (2014).","journal-title":"Nat Rev Clin Oncol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2015.12.002","article-title":"Challenges in circulating tumor cell detection by the CellSearch system","volume":"10","author":"Andree KC","year":"2016","unstructured":"KC Andree, G van Dalum, LW Terstappen, Challenges in circulating tumor cell detection by the CellSearch system. Mol Oncol 10, 395\u2013407 (2016).","journal-title":"Mol Oncol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan D","year":"2011","unstructured":"D Hanahan, RA Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley CT","year":"2016","unstructured":"CT Hensley, , Metabolic heterogeneity in human lung tumors. Cell 164, 681\u2013694 (2016).","journal-title":"Cell"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/JTO.0b013e3181a97df7","article-title":"Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: Prognostic value of positron emission tomography in early-stage non-small cell lung cancer","volume":"4","author":"Dooms C","year":"2009","unstructured":"C Dooms, , Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: Prognostic value of positron emission tomography in early-stage non-small cell lung cancer. J Thorac Oncol 4, 822\u2013828 (2009).","journal-title":"J Thorac Oncol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-010-0884-1","article-title":"Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines","volume":"126","author":"Millon SR","year":"2011","unstructured":"SR Millon, , Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines. Breast Cancer Res Treat 126, 55\u201362 (2011).","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11307-005-0011-6","article-title":"Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells","volume":"7","author":"O\u2019Neil RG","year":"2005","unstructured":"RG O\u2019Neil, L Wu, N Mullani, Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imaging Biol 7, 388\u2013392 (2005).","journal-title":"Mol Imaging Biol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneumeth.2011.09.005","article-title":"In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog","volume":"203","author":"Tsytsarev V","year":"2012","unstructured":"V Tsytsarev, , In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog. J Neurosci Methods 203, 136\u2013140 (2012).","journal-title":"J Neurosci Methods"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nprot.2007.76","article-title":"A real-time method of imaging glucose uptake in single, living mammalian cells","volume":"2","author":"Yamada K","year":"2007","unstructured":"K Yamada, M Saito, H Matsuoka, N Inagaki, A real-time method of imaging glucose uptake in single, living mammalian cells. Nat Protoc 2, 753\u2013762 (2007).","journal-title":"Nat Protoc"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1364\/BOE.2.001514","article-title":"Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue","volume":"2","author":"Langsner RJ","year":"2011","unstructured":"RJ Langsner, , Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue. Biomed Opt Express 2, 1514\u20131523 (2011).","journal-title":"Biomed Opt Express"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist LV","year":"2011","unstructured":"LV Sequist, , Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3, 75ra26 (2011).","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2005.01.388","article-title":"Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib","volume":"23","author":"Han SW","year":"2005","unstructured":"SW Han, , Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 23, 2493\u20132501 (2005).","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch TJ","year":"2004","unstructured":"TJ Lynch, , Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350, 2129\u20132139 (2004).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli M","year":"2004","unstructured":"M Cristofanilli, , Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351, 781\u2013791 (2004).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1158\/2159-8290.CD-11-0215","article-title":"A novel platform for detection of CK+ and CK- CTCs","volume":"1","author":"Pecot CV","year":"2011","unstructured":"CV Pecot, , A novel platform for detection of CK+ and CK- CTCs. Cancer Discov 1, 580\u2013586 (2011).","journal-title":"Cancer Discov"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis WD","year":"2011","unstructured":"WD Travis, , International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6, 244\u2013285 (2011).","journal-title":"J Thorac Oncol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"e4576","DOI":"10.1371\/journal.pone.0004576","article-title":"Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines","volume":"4","author":"Gandhi J","year":"2009","unstructured":"J Gandhi, , Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One 4, e4576 (2009).","journal-title":"PLoS One"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1097-0339(199808)19:2<131::AID-DC14>3.0.CO;2-G","article-title":"Diagnostic problems in serous effusions","volume":"19","author":"Bedrossian CW","year":"1998","unstructured":"CW Bedrossian, Diagnostic problems in serous effusions. Diagn Cytopathol 19, 131\u2013137 (1998).","journal-title":"Diagn Cytopathol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0970-9371.50799","article-title":"Cells in pleural fluid and their value in differential diagnosis","volume":"25","author":"Rashmi K","year":"2008","unstructured":"K Rashmi, P Shashikala, S Hiremath, HG Basavaraj, Cells in pleural fluid and their value in differential diagnosis. J Cytol 25, 138\u2013143 (2008).","journal-title":"J Cytol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0030-1269831","article-title":"Management of the patient with a malignant pleural effusion","volume":"31","author":"Heffner JE","year":"2010","unstructured":"JE Heffner, Management of the patient with a malignant pleural effusion. Semin Respir Crit Care Med 31, 723\u2013733 (2010).","journal-title":"Semin Respir Crit Care Med"},{"key":"e_1_3_4_24_2","first-page":"99","article-title":"Diagnostic approach to pleural effusion","volume":"90","author":"Saguil A","year":"2014","unstructured":"A Saguil, K Wyrick, J Hallgren, Diagnostic approach to pleural effusion. Am Fam Physician 90, 99\u2013104 (2014).","journal-title":"Am Fam Physician"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1373\/clinchem.2015.242537","article-title":"Functional studies on viable circulating tumor cells","volume":"62","author":"Pantel K","year":"2016","unstructured":"K Pantel, C Alix-Panabi\u00e8res, Functional studies on viable circulating tumor cells. Clin Chem 62, 328\u2013334 (2016).","journal-title":"Clin Chem"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/MNM.0b013e32830978c4","article-title":"Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion","volume":"29","author":"Duysinx B","year":"2008","unstructured":"B Duysinx, , Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion. Nucl Med Commun 29, 982\u2013986 (2008).","journal-title":"Nucl Med Commun"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1183\/09031936.00069812","article-title":"Survival of lung adenocarcinoma patients with malignant pleural effusion","volume":"41","author":"Wu SG","year":"2013","unstructured":"SG Wu, , Survival of lung adenocarcinoma patients with malignant pleural effusion. Eur Respir J 41, 1409\u20131418 (2013).","journal-title":"Eur Respir J"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok TS","year":"2009","unstructured":"TS Mok, , Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361, 947\u2013957 (2009).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1158\/1078-0432.CCR-07-1387","article-title":"Epidermal growth factor receptor mutation testing in lung cancer: Searching for the ideal method","volume":"13","author":"Pao W","year":"2007","unstructured":"W Pao, M Ladanyi, Epidermal growth factor receptor mutation testing in lung cancer: Searching for the ideal method. Clin Cancer Res 13, 4954\u20134955 (2007).","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1073\/pnas.1703650114","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000}}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1612229114","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1612229114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T12:18:12Z","timestamp":1719058692000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1612229114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,3,7]]}},"alternative-id":["10.1073\/pnas.1612229114"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1612229114","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727331386.793534245","asserted-by":"object"}]},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]},"assertion":[{"value":"2017-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}